Driving Performance of Depressed Patients who are Untreated or Receive Long-Term Antidepressant (SSRI/SNRI) Treatment

被引:14
作者
van der Sluiszen, Nick N. J. J. M. [1 ]
Wingen, Marleen [1 ]
Vermeeren, Annemiek [1 ]
Vinckenbosch, Frederick [1 ]
Jongen, Stefan [1 ]
Ramaekers, Johannes G. [1 ]
机构
[1] Maastricht Univ, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands
关键词
antidepressants; depression; driving performance; long-term treatment; ROAD-TRAFFIC ACCIDENTS; PSYCHOMOTOR FUNCTION; MIRTAZAPINE; IMPAIRMENT; DISORDER; DRIVERS; ALCOHOL; YOUNG;
D O I
10.1055/s-0043-111600
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction Depression is a mental disorder likely to affect everyday functions. The present study aimed to assess actual driving performance of depressed patients who were without specific antidepressant treatment or received long-term antidepressant treatment. Methods A standardized on-the-road driving test was used to assess standard deviation of lateral position (SDLP) in 3 patient groups receiving either no antidepressant treatment (with or without benzodiazepine medication) or treatment with selective serotonin/noradrenalin reuptake inhibitors for a period of 6-52 weeks. Severity of depression was assessed using Beck's Depression Inventory and the Hamilton Depression Rating Scale. The performance of patient groups was compared to healthy controls. Results The mean SDLP of untreated and treated patients was significantly higher than that of healthy controls. Driving impairment in the long-term treated group was significantly less than in the untreated groups. SDLP was positively correlated to severity of depression across all groups. Discussion It is concluded that symptoms of depression are a major cause of driving impairment. Reductions in severity of depression through antidepressant treatment reduce severity of driving impairment.
引用
收藏
页码:182 / 188
页数:7
相关论文
共 50 条
  • [41] Assessment of long-term cognitive dysfunction in older patients who undergo heart surgery
    Florido-Santiago, M.
    Perez-Belmonte, L. M.
    Osuna-Sanchez, J.
    Barbancho, M. A.
    Ricci, M.
    Millan-Gomez, M.
    Bernal-Lopez, M. R.
    Gomez-Huelgas, R.
    Lara, J. P.
    NEUROLOGIA, 2023, 38 (06): : 399 - 404
  • [42] The Effect of Bariatric Surgery on Long-term Depression Treatment in Patients With Obesity
    Smith, Valerie A.
    Maciejewski, Matthew L.
    Berkowitz, Theodore S. Z.
    Mitchell, James E.
    Liu, Chuan-Fen
    Bradley, Katharine A.
    Olsen, Maren K.
    Livingston, Edward L.
    Arterburn, David E.
    ANNALS OF SURGERY, 2022, 276 (02) : 318 - 323
  • [43] Attitudes and preferences in patients with acromegaly on long-term treatment with somatostatin analogues
    Follin, Cecilia
    Karlsson, Sven
    ENDOCRINE CONNECTIONS, 2016, 5 (04): : 167 - 173
  • [44] Amisulpride: A safe and effective option for the long-term treatment of patients with schizophrenia
    Naber, D
    Arlt, J
    Lambert, M
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2003, 7 (03) : 167 - 175
  • [45] Long-term fingolimod treatment in two pediatric patients with multiple sclerosis
    Borriello, Giovanna
    Pozzilli, Carlo
    NEUROLOGICAL SCIENCES, 2021, 42 (SUPPL 1) : 29 - 36
  • [46] LONG-TERM NITRAZEPAM TREATMENT IN PSYCHIATRIC OUT-PATIENTS WITH INSOMNIA
    KANGAS, L
    KANTO, J
    LEHTINEN, V
    SALMINEN, J
    PSYCHOPHARMACOLOGY, 1979, 63 (01) : 63 - 66
  • [47] Long-term treatment of pulmonary arterial hypertension with macitentan in Japanese patients
    Tahara, Nobuhiro
    Dobashi, Hiroaki
    Fukuda, Keiichi
    Funauchi, Masanori
    Hatano, Masaru
    Ikeda, Satoshi
    Joho, Shuji
    Kihara, Yasuki
    Kondo, Takahisa
    Matsushita, Masakazu
    Minamino, Tohru
    Nakanishi, Norifumi
    Okano, Yoshiaki
    Ozaki, Yukio
    Saji, Tsutomu
    Sakai, Satoshi
    Tanabe, Nobuhiro
    Watanabe, Hiroshi
    Yamada, Hidehiro
    Yoshioka, Koichiro
    Hatta, Motonori
    Sasayama, Shigetake
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (06) : 921 - 928
  • [48] Sustained Treatment Response With Long-Term Valbenazine in Patients With Tardive Dyskinesia
    Correll, Christoph
    Lindenmayer, Jean-Pierre
    Farah-Mand, Khodayar
    Siegert, Scott
    Dunayevich, Eduardo
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 344 - 345
  • [49] Sustained Treatment Response With Long-Term Valbenazine in Patients With Tardive Dyskinesia
    Correll, Christoph
    Lindenmayer, Jean-Pierre
    Farahmand, Khodayar
    Siegert, Scott
    Dunayevich, Eduardo
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 344 - 345
  • [50] Long-term fingolimod treatment in two pediatric patients with multiple sclerosis
    Giovanna Borriello
    Carlo Pozzilli
    Neurological Sciences, 2021, 42 : 29 - 36